T3	Subject 10 20	2 patients
T5	Effect 35 55	polyarteritis nodosa
T6	Treatment 66 97	vaccination against hepatitis B
T7	Population 10 11	2
T8	Drug 66 97	vaccination against hepatitis B
T4	Adverse_event 25 34	developed
E1	Adverse_event:T4 
